USPTO serial 90609749
AUREGEN BIOTHERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 17, 2024
- Examiner
- SHOOR, AMIT KUMAR
- Law office
- Historical data usage
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AUREGEN BIOTHERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
LEIGH ANN LINDQUIST
LEIGH ANN LINDQUIST SUGHRUE MION, PLLC2000 PENNSYLVANIA AVENUE NW, SUITE 9000WASHINGTON, DC 20006United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells for research purposes; stem cells for scientific purposes; stem cells for research or scientific purposes; stem cells other than for medical or veterinary purposes; hydrogel polymer edible coatings for tablets; Lactic acid polymers for use in the manufacture of capsules for pharmaceuticals; Aqueous linear polymer gels for use in the manufacture of capsules for pharmaceuticals; Chemical preparations in the nature of photo curable resin compositions comprising polymers for scientific purposes; chemicals for use in polymerisations; engineered biological tissues and tissue arrays, namely, human and animal organ, connective, epithelial, muscular, and nervous tissues and tissue arrays, for use in scientific and medical research; biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue for research and scientific purposes; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment | ACTIVE | — |
| 005 | Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs for replacing and/or for supporting the function of missing or damaged body parts; Medical preparations based on cellulous nano-fibrils for use in the 3D bio-printing of tissues and organs for medical use; tissue-regenerative pharmaceutical preparations; Biological bone, skin tissue intended for subsequent implantation for skin and cartilage; biological skin and cartilage tissue intended for subsequent implantation; cells for medical use; human allograft tissue; living cells for medical use; Surgical implants comprised of living tissues for guided tissue regeneration; implants comprising living tissue; Implants comprised of living tissue for use in guided tissue regeneration; skin grafts; surgical implants comprised of living tissues; surgical implants of living tissues grown from stem cells; transdermal patches for use to create skin for prosthetic limbs and for skin grafts; Implants comprised of living tissues for transplant; antibodies for use to create skin for prosthetic limbs and for skin grafts; stem cells for medical purposes; engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, connective, epithelial, muscular, and nervous tissue and organs, for medical purposes; biological molecules to assist in the development of tissue for medical purposes; hemostatic gel matrix preparations for treating wounds; natural biomaterials for augmentation of bone, blood and tissue for medical purposes; processed human donor skin for the replacement of soft tissue; pharmaceutical products for tissue regeneration, for tissue repair, for tissue treatment, whether relating to human or animal tissue; pharmaceutical preparations for the treatment of bone diseases, for cartilaginous diseases, for vascular diseases, for neuronal degeneration, for degeneration of tendons and ligaments, for retinal degeneration, for renal degeneration, degeneration of soft tissue, for diseases with abnormal cell proliferation; natural biomaterials for bone filling for medical purposes; natural biomaterials for filling cartilage for medical purposes; stem cells for medical use; surgical implants of living tissue; surgical cloths for wound protection; surgical implants grown from stem cells and comprised of living tissue; biological tissue cultures for medical use, all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment; Cartridges containing printing material for use with three dimensional printers, filled with natural biomaterials for augmentation of bone and tissue for medical purposes; Cartridges for use with three dimensional printers filled bioprinting material in the nature of living tissue for medical purposes; printing cartridges for use with three dimensional printers, containing bioink in the nature of living tissue for medical purposes | ACTIVE | — |
| 007 | Three-dimensional (3D) printers; three-dimensional (3D) bioprinters; Machines in the nature of computerized equipment for the generation of three-dimensional shaped parts; machines for manufacturing three dimensional models, namely, computer-aided modeling devices; machines for manufacturing three dimensional (3D) living tissues; machines, namely, three dimensional (3D) bioprinter for the printing of living tissues; cartridges for containing printing material for use with three dimensional printers, sold empty; cartridges for containing bioprinting material for use with three dimensional printers, sold empty; printing cartridges for containing biomaterial for use with three dimensional printers, sold empty; printing cartridges for containing bioink for use with three dimensional printers, sold empty; 3D printers incorporating an imaging device for use in research on biomaterials for the creation of prosthetic limbs and grafts; Combination 3D printers incorporating laboratory apparatus for use in research on biomaterials for the creation of prosthetic limbs and grafts; Combination 3D printers incorporating a scientific research and laboratory apparatus and instruments for research on biomaterials for the creation of prosthetic limbs and grafts in the field of cytology | ACTIVE | — |
| 009 | Laboratory apparatus for fabrication of three-dimensional tissues and organs; Biochips for the production of three-dimensional living tissues and organs for research or scientific purposes; bioreactor for cell culturing; bioreactors for laboratory use; bioreactors for research use; cell culture apparatus for laboratory use, namely, cell culture dishes, tissue culture flasks; Nonmedical combination imaging device incorporating a 3D printer for use in research on biomaterials for the creation of prosthetic limbs and grafts; Laboratory apparatus and instruments, namely, apparatus and instruments for thermal imaging, detecting pathogens, performing DNA analysis, incubator, microscope, function generators, oscilloscopes for use in research on biomaterials, also incorporating a 3D printer, for the creation of prosthetic limbs and grafts; print heads for inkjet printers; Scientific research and laboratory apparatus and instruments, namely, apparatus and instruments for thermal imaging, detecting pathogens, performing DNA analysis, incubator, microscope, function generators, oscilloscopes for research on biomaterials, also incorporating a 3D printer, for the creation of prosthetic limbs and grafts in the field of cytology; Laboratory apparatus and instruments, namely, apparatus and instruments for thermal imaging, detecting pathogens, performing DNA analysis, incubator, microscope, function generators, oscilloscopes for research on biomaterials, also incorporating a 3D printer, for the creation of prosthetic limbs and grafts for use in biopharmaceutical discovery and development; Laboratory apparatus and instruments, namely, apparatus and instruments for thermal imaging, detecting pathogens, performing DNA analysis, incubator, microscope, function generators, oscilloscopes for research on biomaterials, also incorporating a 3D printer, for the creation of prosthetic limbs and grafts; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment | ACTIVE | — |
| 010 | Dental apparatus and instruments, including imaging devices, for medical purposes, for use in dental surgery; surgical synthetic modified implants and transplants with endogenous material, tissue cells or molecules made of synthetic materials for replacement and/or for supporting the function of missing or damaged body parts, not for cardiac disease treatment; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment; all of the above for synthetic implants | ACTIVE | — |
| 040 | 3D printing services for others; Custom 3D printing services; renting of 3D printers; creation of customized three-dimensional shaped parts using rapid prototyping equipment; 3D bioprinting for others; Bioprinting for others; Research in the field of three-dimensional (3D) printing in the nature of bioprinting for others; Technical consultancy in the field of rapid prototype fabrication of new products for others | ACTIVE | — |
| 042 | Technical research in the fields of biomimetics, biomaterials, material adaptation, 3D bioprinting and tissue engineering; research and development of medical devices; research in the field of nanotechnology and nanomaterials; synthetic biology research; robotics research; bioengineering research; nanotherapeutics research; Biological research in the field of three-dimensional (3D) bioprinting; tissue engineering research; research and development of 3D technology and processes; development of rapid prototyping equipment; scientific research consulting in the fields of three-dimensional printing; scientific services relating to the isolation and cultivation of human tissues and cells; scientific and medical research and development in the field of bio-printing; scientific and medical research and development in the field of tissue manufacturing; Tissue engineering in the nature of development and culture of artificial tissues and cells; Tissue engineering services in the nature of development and culture of artificial tissues and cells for scientific and research purposes; Scientific and medical research and analysis services in the field of tissue engineering research, regenerative biotherapies, genomics, biotechnology, chemicals and pharmaceuticals; Scientific research and material testing services in the fields of regenerative biotherapies, genomics, biotechnology, chemicals and pharmaceuticals; research and development of new products for others in the fields of regenerative biotherapies, genomics, biotechnology, chemicals and pharmaceuticals; Autologous and allogeneic tissue engineering in the nature of development and culture of artificial tissues and cells for scientific and research purposes; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment | ACTIVE | — |
| 044 | Medical services, namely, in the field of gene and cellular immunotherapies and transplantation; Medical diagnostic monitoring and reporting of testing services; human cell and tissue banking services; collection and preservation of human blood and cells for medical use; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment; medical treatment services; consulting services in the fields of medical treatment and medicines; medical services, namely, plastic surgery and microsurgery, in particular reshaping noses (rhinoplasty) for either cosmetic or reconstructive purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Auregen BioTherapeutics SA
- Other trademarks owned by Auregen BioTherapeutics SA
- Other trademarks owned by Auregen BioTherapeutics SA
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AUREGEN BIOTHERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 3, 2025 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| May 15, 2025 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| May 6, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 19, 2024 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Dec 17, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 17, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 3, 2024 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Jul 3, 2024 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jun 20, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 20, 2024 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Feb 20, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 26, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 26, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 6, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 20, 2023 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Nov 20, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 18, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 18, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 18, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 18, 2023 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Oct 18, 2023 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jul 19, 2023 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Jul 19, 2023 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Jul 19, 2023 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Jun 12, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 3, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 1, 2023 | ALIE | ASSIGNED TO LIE | — |
| Mar 24, 2023 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Mar 13, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 13, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 13, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 13, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 7, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 7, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 7, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 18, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 18, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 16, 2022 | ALIE | ASSIGNED TO LIE | — |
| May 10, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 10, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 10, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 10, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 11, 2021 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Aug 11, 2021 | ALIE | ASSIGNED TO LIE | — |
| Aug 6, 2021 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jul 4, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 1, 2021 | NWAP | NEW APPLICATION ENTERED | — |